Core A
Core A
批准号:
8102898
负责人:
Steven Daniel Douglas
金额:
$17.25万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2014-07-31
关键词:
AIDS neuropathyClinicalCollaborationsCommunicationDecision MakingDevelopment PlansExpenditureFosteringGoalsGuidelinesIndividualInformation DisseminationInstitutionIntellectual PropertyLeadershipMissionNational Institute of Mental HealthParticipantPoliciesPrincipal InvestigatorProceduresProcessProgram DevelopmentPublicationsResearchResearch ActivityResearch PersonnelResearch PriorityResource AllocationResourcesRoleScientistServicesSpecific qualifier valueSupervisionTechnology TransferTherapeuticTimeLineU-Series Cooperative AgreementsUnited States National Institutes of Healthdata sharingdesigndrug developmentinnovationmeetingsnoveloperationpre-clinicalprogramsresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core A will serve all projects and cores in the Novel neuroAIDS Therapies: Integrated Preclinical/Clinical
IPCP and will be responsible for oversight ofthe scientific, administrative, regulatory and operational aspects
of the program's activities. The overall goal of the Administrative Core is to enable the IPCP to fulfill its
scientific mission, as defined in the introduction and overview at the beginning of this proposal, as a specified
in the Specific Aims of the three projects. The Principal Investigator, Dr. Steven D. Douglas, will direct this
core and will provide leadership, direction, and organization to the overall program project effort and assist
each of the Project Leaders and Core Leaders in the successful execution of their planned experiments or
support services. The objectives ofthe Administrative Core are to: (1) Coordinate and supervise this IPCP;
(2) Oversee the development plan ofthe IPCP by coordinating regular review of study results and integration
of this information into the decision-making process that is integral to the drug development mission of the
research program; (3) Promote a high degree of collaboration and synergistic interaction among the
investigators and core leaders; (4) Facilitate participation of this IPCP within NIH IPCP Program activities; (5)
Insure efficient and appropriate use of core services by the individual projects; (6) Provide investigators and
core directors with timely and accurate information regarding core and project expenditures and resources;
(7) Insure that the program's development plan is conducted in compliance with all applicable regulatory
guidelines and NIH policies and procedures; (8) Organize and implement regular internal and external
oversight of the IPCP's activities; and, (9) Support the program in fulfilling its obligations related to
information dissemination, scientific publication and data sharing. This will include management of
intellectual property issues in collaboration with the CHOP Department of Technology Transfer. The
Administrative Core will be utilized equally by all participating projects and scientific cores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS
-
批准号:8929300
-
项目类别:
-
资助金额:$104.3万
-
财政年份:2014
-
负责人:Steven Daniel Douglas
-
依托单位:
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS
-
批准号:9288214
-
项目类别:
-
资助金额:$107.07万
-
财政年份:2014
-
负责人:Steven Daniel Douglas
-
依托单位:
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS
-
批准号:8790645
-
项目类别:
-
资助金额:$111.05万
-
财政年份:2014
-
负责人:Steven Daniel Douglas
-
依托单位:
Core E: Laboratory and biobehavioral marker core
-
批准号:10090667
-
项目类别:
-
资助金额:$23.82万
-
财政年份:2013
-
负责人:Steven Daniel Douglas
-
依托单位:
CD163 in HIV Immunopathogenesis
-
批准号:8601783
-
项目类别:
-
资助金额:$23.62万
-
财政年份:2013
-
负责人:Steven Daniel Douglas
-
依托单位:
NEUROKININ-1 RECEPTOR EXPRESSION IN THE BRAINS OF SIV-INFECTED RHESUS MACAQUES
-
批准号:8358142
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:Steven Daniel Douglas
-
依托单位:
Project 5
-
批准号:8102897
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2010
-
负责人:Steven Daniel Douglas
-
依托单位:
NEUROKININ-1 RECEPTOR EXPRESSION IN THE BRAINS OF SIV-INFECTED RHESUS MACAQUES
-
批准号:8173056
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Steven Daniel Douglas
-
依托单位:
Project 2
-
批准号:8102895
-
项目类别:
-
资助金额:$21.62万
-
财政年份:2010
-
负责人:Steven Daniel Douglas
-
依托单位:
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists
-
批准号:8303327
-
项目类别:
-
资助金额:$112.34万
-
财政年份:2009
-
负责人:Steven Daniel Douglas
-
依托单位:
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists
-
批准号:8526560
-
项目类别:
-
资助金额:$108.67万
-
财政年份:2009
-
负责人:Steven Daniel Douglas
-
依托单位:
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists
-
批准号:7894593
-
项目类别:
-
资助金额:$113.83万
-
财政年份:2009
-
负责人:Steven Daniel Douglas
-
依托单位:
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists
-
批准号:8102900
-
项目类别:
-
资助金额:$112.57万
-
财政年份:2009
-
负责人:Steven Daniel Douglas
-
依托单位:
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists
-
批准号:7881910
-
项目类别:
-
资助金额:$116.63万
-
财政年份:2009
-
负责人:Steven Daniel Douglas
-
依托单位:
Project 2
-
批准号:7890832
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2009
-
负责人:Steven Daniel Douglas
-
依托单位:
Core A
-
批准号:7659760
-
项目类别:
-
资助金额:$14.78万
-
财政年份:2008
-
负责人:Steven Daniel Douglas
-
依托单位:
Neurokinin-1R Antagonists-Cellular And Molecular Mechanisms
-
批准号:7658846
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2008
-
负责人:Steven Daniel Douglas
-
依托单位:
Neurokinin-1R Antagonists-Cellular And Molecular Mechanisms
-
批准号:7516467
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2007
-
负责人:Steven Daniel Douglas
-
依托单位:
Philadelphia IMPAACT Clinical Trials Unit
-
批准号:7096402
-
项目类别:
-
资助金额:$164.16万
-
财政年份:2007
-
负责人:Steven Daniel Douglas
-
依托单位:
Philadelphia IMPAACT Clinical Trials Unit
-
批准号:7999214
-
项目类别:
-
资助金额:$183.87万
-
财政年份:2007
-
负责人:Steven Daniel Douglas
-
依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: